Therapeutic effectiveness of prostaglandins (PGs) in peripheral vascular disease (PVD).
Linet
O I
OI
Upjohn Company, Kalamazoo, MI 49001.
Mohberg
N R
NR
D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D000671:Amputation, Surgical; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016285:Iloprost; D007262:Infusions, Intravenous; D007871:Leg Ulcer / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D002317:Cardiovascular Agents; D011464:Epoprostenol; D000527:Alprostadil; D016285:Iloprost